An official website of the United States government
Rates* of reported cases† of acute Hepatitis C virus infection, by state or jurisdiction — United States, 2020–2021
Source: CDC, National Notifiable Diseases Surveillance System.
* Rates per 100,000 population. Rate calculations used bridged-race population estimates in 2020 and single-race population estimates in 2021.
† Reported confirmed cases. For the case definition, see Acute Hepatitis C.
Only states with rates for 2020 and 2021 are shown. State/jurisdiction and year for no reported cases: Hawaii (2020, 2021), Idaho (2021), New Mexico (2021), North Dakota (2020, 2021), Vermont (2021), Wyoming (2020); for not reportable: Alaska (2020, 2021); for unavailable data: Arizona (2020, 2021), District of Columbia (2020, 2021), Rhode Island (2020, 2021).
State or jurisdiction ranked in decreasing order by the 2021 rate, 2020 rate, and then alphabetical order by name.
During 2021, the rates of reported acute hepatitis C ranged from a high of 9.8 cases per 100,000 population in Maine to a low of ≤0.1 or less cases per 100,000 population in South Carolina, Colorado, Kansas, Mississippi, and Texas. The largest absolute increase in rates was observed in Utah, with a rate during 2021 of 4.5 cases per 100,000 population, at increase of 41% compared to the rate in 2020 of 3.2 cases per 100,000 population. The largest absolute decrease was observed in Maine, where the rate of 9.8 cases per 100,000 population in 2021 was an 18% decrease from the rate of 11.9 cases per 100,000 population in 2020. Because of the relatively smaller number of acute hepatitis C cases reported in certain jurisdictions, wide fluctuations in annual rates might occur.
- Figure 3.1. Number of reported cases of acute hepatitis C virus infection and estimated infections — United States, 2014–2021
- Figure 3.2. Rates of reported cases of acute hepatitis C virus infection, by state or jurisdiction — United States, 2020–2021
- Figure 3.3. Rates of reported cases of acute hepatitis C virus infection, by state or jurisdiction — United States, 2021
- Figure 3.4. Rates* of reported cases of acute hepatitis C virus infection, by age group — United States, 2006–2021
- Figure 3.5. Rates of reported cases of acute hepatitis C virus infection, by sex — United States, 2006–2021
- Figure 3.6. Rates of reported cases of acute hepatitis C virus infection, by race/ethnicity — United States, 2006–2021
- Figure 3.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis C virus infection — United States, 2021
- Figure 3.8. Number of newly reported chronic hepatitis C virus infection cases by sex and age — United States, 2021
- Figure 3.9. Rates of death with hepatitis C virus infection listed as a cause of death among residents, by state or jurisdiction — United States, 2021
- Table 3.1. Numbers and rates of reported cases† of acute hepatitis C virus infection, by state or jurisdiction — United States, 2017–2021
- Table 3.2. Numbers and rates of reported cases† of acute hepatitis C virus infection, by demographic characteristics — United States, 2017–2021
- Table 3.3. Reported risk behaviors or exposures among reported cases of acute hepatitis C virus infection — United States, 2021
- Table 3.4. Number of newly reported cases of perinatal hepatitis C virus infection, by state or jurisdiction — United States, 2021
- Table 3.5. Number and rate of newly reported cases of chronic hepatitis C virus infection, by state or jurisdiction — United States, 2021
- Table 3.6. Number and rate of newly reported cases of chronic hepatitis C virus infection, by demographic characteristics — United States, 2021
- Table 3.7. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2017–2021
- Table 3.8. Numbers and rates of deaths with hepatitis C virus infection listed as a cause of death among residents, by demographic characteristics — United States, 2017–2021